Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pradaxa in acute pancreatitis
NCT03807856Phase 1Terminated
- Sponsor
- Mayo Clinic
- Start
- Jun 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dabigatran in acute pancreatitis (AP), sponsored by Mayo Clinic. Started Jun 2019; status: terminated.
02
Drugs
dabigatran
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT03807856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03807856.